Cancer Conversations™ in RCC: Improving Outcomes With Immunotherapy and Targeted Agents

Improve your knowledge and apply expert insights on current treatment options for RCC from selecting first-line therapy through understanding treatment options after multiple lines of treatment. View a discussion by experts in an on-demand webcast from a live webinar and then download the slides for use in your own presentations.

Share

Program Content

No activities added yet

Activities

IO and Targeted Agents in RCC
Cancer Conversations™:
Improving Outcomes With Immunotherapy and Targeted Agents in RCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 01, 2021

Expires: October 31, 2022

<i>EP</i>: IO and Targeted Agents in RCC
ExpressPoints Cancer Conversations™: Improving Outcomes With Immunotherapy and Targeted Agents in RCC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 01, 2021

Expires: October 31, 2022

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Eisai

Exelixis, Inc.

Merck Sharp & Dohme Corp.